Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 21, 2003Antimicrobial Agents and ChemotherapyOpen Access

Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies

View Full Paper
Ask AI
Bookmark
Share

Authors

EREthan RubinsteinMedStar Washington Hospital CenterRIRaúl IstúrizPfizer (United States)HSHarold C. StandifordUniversity of Maryland, Baltimore

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rubinstein et al. (2003) studied this question.

synapsesocial.com/papers/6a65a0c266b3f59c44c4d9cdhttps://doi.org/10.1128/aac.47.6.1824-1831.2003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents1996 · 462 citations
  2. 2Methylmercury and Neurodevelopment: Reanalysis of the Seychelles Child Development Study Outcomes at 66 Months of Age2001 · 50 citations
  3. 3Linezolid Versus Ceftriaxone/Cefpodoxime in Patients Hospitalized for the Treatment of Streptococcus pneumoniae Pneumonia2002 · 68 citations